2024-04-012025-03-312025-03-31false13001581RAVI LINGAM RADIOLOGY SERVICES LIMITED2025-08-08falseiso4217:GBPxbrli:pure130015812024-03-31130015812025-03-31130015812024-04-012025-03-31130015812023-03-31130015812024-03-31130015812023-04-012024-03-3113001581bus:SmallEntities2024-04-012025-03-3113001581bus:AuditExempt-NoAccountantsReport2024-04-012025-03-3113001581bus:FullAccounts2024-04-012025-03-3113001581bus:PrivateLimitedCompanyLtd2024-04-012025-03-3113001581core:WithinOneYear2025-03-3113001581core:AfterOneYear2025-03-3113001581core:WithinOneYear2024-03-3113001581core:AfterOneYear2024-03-3113001581core:ShareCapital2025-03-3113001581core:SharePremium2025-03-3113001581core:RevaluationReserve2025-03-3113001581core:OtherReservesSubtotal2025-03-3113001581core:RetainedEarningsAccumulatedLosses2025-03-3113001581core:ShareCapital2024-03-3113001581core:SharePremium2024-03-3113001581core:RevaluationReserve2024-03-3113001581core:OtherReservesSubtotal2024-03-3113001581core:RetainedEarningsAccumulatedLosses2024-03-3113001581core:LandBuildings2025-03-3113001581core:PlantMachinery2025-03-3113001581core:Vehicles2025-03-3113001581core:FurnitureFittings2025-03-3113001581core:OfficeEquipment2025-03-3113001581core:NetGoodwill2025-03-3113001581core:IntangibleAssetsOtherThanGoodwill2025-03-3113001581core:ListedExchangeTraded2025-03-3113001581core:UnlistedNon-exchangeTraded2025-03-3113001581core:LandBuildings2024-03-3113001581core:PlantMachinery2024-03-3113001581core:Vehicles2024-03-3113001581core:FurnitureFittings2024-03-3113001581core:OfficeEquipment2024-03-3113001581core:NetGoodwill2024-03-3113001581core:IntangibleAssetsOtherThanGoodwill2024-03-3113001581core:ListedExchangeTraded2024-03-3113001581core:UnlistedNon-exchangeTraded2024-03-3113001581core:LandBuildings2024-04-012025-03-3113001581core:PlantMachinery2024-04-012025-03-3113001581core:Vehicles2024-04-012025-03-3113001581core:FurnitureFittings2024-04-012025-03-3113001581core:OfficeEquipment2024-04-012025-03-3113001581core:NetGoodwill2024-04-012025-03-3113001581core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3113001581core:ListedExchangeTraded2024-04-012025-03-3113001581core:UnlistedNon-exchangeTraded2024-04-012025-03-3113001581core:MoreThanFiveYears2024-04-012025-03-3113001581core:Non-currentFinancialInstruments2025-03-3113001581core:Non-currentFinancialInstruments2024-03-3113001581dpl:CostSales2024-04-012025-03-3113001581dpl:DistributionCosts2024-04-012025-03-3113001581core:LandBuildings2024-04-012025-03-3113001581core:PlantMachinery2024-04-012025-03-3113001581core:Vehicles2024-04-012025-03-3113001581core:FurnitureFittings2024-04-012025-03-3113001581core:OfficeEquipment2024-04-012025-03-3113001581dpl:AdministrativeExpenses2024-04-012025-03-3113001581core:NetGoodwill2024-04-012025-03-3113001581core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3113001581dpl:GroupUndertakings2024-04-012025-03-3113001581dpl:ParticipatingInterests2024-04-012025-03-3113001581dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3113001581core:ListedExchangeTraded2024-04-012025-03-3113001581dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3113001581core:UnlistedNon-exchangeTraded2024-04-012025-03-3113001581dpl:CostSales2023-04-012024-03-3113001581dpl:DistributionCosts2023-04-012024-03-3113001581core:LandBuildings2023-04-012024-03-3113001581core:PlantMachinery2023-04-012024-03-3113001581core:Vehicles2023-04-012024-03-3113001581core:FurnitureFittings2023-04-012024-03-3113001581core:OfficeEquipment2023-04-012024-03-3113001581dpl:AdministrativeExpenses2023-04-012024-03-3113001581core:NetGoodwill2023-04-012024-03-3113001581core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3113001581dpl:GroupUndertakings2023-04-012024-03-3113001581dpl:ParticipatingInterests2023-04-012024-03-3113001581dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-012024-03-3113001581core:ListedExchangeTraded2023-04-012024-03-3113001581dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-012024-03-3113001581core:UnlistedNon-exchangeTraded2023-04-012024-03-3113001581core:NetGoodwill2025-03-3113001581core:IntangibleAssetsOtherThanGoodwill2025-03-3113001581core:LandBuildings2025-03-3113001581core:PlantMachinery2025-03-3113001581core:Vehicles2025-03-3113001581core:FurnitureFittings2025-03-3113001581core:OfficeEquipment2025-03-3113001581core:AfterOneYear2025-03-3113001581core:WithinOneYear2025-03-3113001581core:ListedExchangeTraded2025-03-3113001581core:UnlistedNon-exchangeTraded2025-03-3113001581core:ShareCapital2025-03-3113001581core:SharePremium2025-03-3113001581core:RevaluationReserve2025-03-3113001581core:OtherReservesSubtotal2025-03-3113001581core:RetainedEarningsAccumulatedLosses2025-03-3113001581core:NetGoodwill2024-03-3113001581core:IntangibleAssetsOtherThanGoodwill2024-03-3113001581core:LandBuildings2024-03-3113001581core:PlantMachinery2024-03-3113001581core:Vehicles2024-03-3113001581core:FurnitureFittings2024-03-3113001581core:OfficeEquipment2024-03-3113001581core:AfterOneYear2024-03-3113001581core:WithinOneYear2024-03-3113001581core:ListedExchangeTraded2024-03-3113001581core:UnlistedNon-exchangeTraded2024-03-3113001581core:ShareCapital2024-03-3113001581core:SharePremium2024-03-3113001581core:RevaluationReserve2024-03-3113001581core:OtherReservesSubtotal2024-03-3113001581core:RetainedEarningsAccumulatedLosses2024-03-3113001581core:NetGoodwill2023-03-3113001581core:IntangibleAssetsOtherThanGoodwill2023-03-3113001581core:LandBuildings2023-03-3113001581core:PlantMachinery2023-03-3113001581core:Vehicles2023-03-3113001581core:FurnitureFittings2023-03-3113001581core:OfficeEquipment2023-03-3113001581core:AfterOneYear2023-03-3113001581core:WithinOneYear2023-03-3113001581core:ListedExchangeTraded2023-03-3113001581core:UnlistedNon-exchangeTraded2023-03-3113001581core:ShareCapital2023-03-3113001581core:SharePremium2023-03-3113001581core:RevaluationReserve2023-03-3113001581core:OtherReservesSubtotal2023-03-3113001581core:RetainedEarningsAccumulatedLosses2023-03-3113001581core:AfterOneYear2024-04-012025-03-3113001581core:WithinOneYear2024-04-012025-03-3113001581core:Non-currentFinancialInstrumentscore:CostValuation2024-04-012025-03-3113001581core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-012025-03-3113001581core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-012025-03-3113001581core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-012025-03-3113001581core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-012025-03-3113001581core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-012025-03-3113001581core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3113001581core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3113001581core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3113001581core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3113001581core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3113001581core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3113001581core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3113001581core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3113001581core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3113001581core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3113001581core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3113001581core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3113001581core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3113001581core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3113001581core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3113001581core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3113001581core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3113001581core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3113001581core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3113001581core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3113001581core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3113001581bus:Director12024-04-012025-03-31

RAVI LINGAM RADIOLOGY SERVICES LIMITED

Registered Number
13001581
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2025

RAVI LINGAM RADIOLOGY SERVICES LIMITED
Company Information
for the year from 1 April 2024 to 31 March 2025

Director

RAMALINGAM, Ravi Kumar, Dr

Registered Address

Suite 20 Pluto Accountancy New Mead Barn Wickham Hall
Hadham Road
Bishop's Stortford
CM23 1JG

Registered Number

13001581 (England and Wales)
RAVI LINGAM RADIOLOGY SERVICES LIMITED
Balance Sheet as at
31 March 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Tangible assets335,91544,894
Investments4350,588250,332
386,503295,226
Current assets
Debtors-644
Current asset investments5217,000157,000
Cash at bank and on hand38,01966,171
255,019223,815
Creditors amounts falling due within one year6(48,503)(56,408)
Net current assets (liabilities)206,516167,407
Total assets less current liabilities593,019462,633
Net assets593,019462,633
Capital and reserves
Called up share capital100100
Profit and loss account592,919462,533
Shareholders' funds593,019462,633
The financial statements were approved and authorised for issue by the Director on 8 August 2025, and are signed on its behalf by:
RAMALINGAM, Ravi Kumar, Dr
Director
Registered Company No. 13001581
RAVI LINGAM RADIOLOGY SERVICES LIMITED
Notes to the Financial Statements
for the year ended 31 March 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:
Investments
Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value where the difference between cost and fair value is material. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.
2.Average number of employees

20252024
Average number of employees during the year11
3.Tangible fixed assets

Vehicles

Office Equipment

Total

£££
Cost or valuation
At 01 April 2471,57711,94583,522
At 31 March 2571,57711,94583,522
Depreciation and impairment
At 01 April 2434,9303,69838,628
Charge for year7,3291,6508,979
At 31 March 2542,2595,34847,607
Net book value
At 31 March 2529,3186,59735,915
At 31 March 2436,6478,24744,894
4.Fixed asset investments

Other investments1

Total

££
Cost or valuation
At 01 April 24250,332250,332
Additions88,50088,500
Revaluations11,75611,756
At 31 March 25350,588350,588
Net book value
At 31 March 25350,588350,588
At 31 March 24250,332250,332

Notes

1Other investments other than loans
5.Current asset investments
6.Creditors: amounts due within one year

2025

2024

££
Taxation and social security45,73547,652
Other creditors888576
Accrued liabilities and deferred income1,8808,180
Total48,50356,408